$HIPH- Today's new Press Release/ News! $HIPH Strong

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
287
$HIPH- Today's new Press Release/ News! $HIPH Strong technical buy! Closes JV deal to sell in China & Asia markets. $HIPH a bargain in my opinion

(See below this mornings PR)



PLAYA VISTA, CA / ACCESSWIRE / March 15, 2018 / American Premium Water Corporation (OTC PINK: HIPH) announces that its Gents subsidiary has entered into a joint venture with Zhangjiagang Advanced Company (ZAC) to market and sell Gents in China and other Asian markets.

American Premium Water Corporation (OTC PINK: HIPH) is pleased to announce that Gents has agreed to a joint venture with Zhangjigang to market and sell the Gents brand line of products throughout mainland China and other countries in eastern Asia. HIPH is also exploring partnerships for LALPINA Hydrogen CBD distribution in the region as well.

Ryan Fishoff, CEO American Premium Water Corporation stated, "This is a significant step for the brand to expand internationally. Working together with ZATC, we have a partner that will help us expand our footprint internationally and establish a presence in the world's largest market. It also establishes a base to setup distribution in other major markets in the area, including Japan and Korea."

Fred Su, Principal of ZAC spoke of the partnership "I am really excited, and looking forward to our new partnership with the Gents premium brand and introducing them to the Chinese market. The Chinese population loves premium American brands, and I think Gents has the potential to capture a large part of the market that continues to grow rapidly. We will have special collections created exclusively for the Asian markets which will further establish the brand in our country."

Mr. Fishoff is currently in China this week to execute the agreement and set the strategy for the launch. Gents will create an e-commerce site exclusively for the Chinese market and will also sell products on JD.com (JD). The tentative launch for the collaboration will be for Fathers Day, as its celebrated at the same time in both the US and China.

Mr. Fishoff added, "I am excited to go to China to personally see the initiation of this partnership and plot out our strategic plans for the rest of 2018. This is just the first piece of a broader international strategy for Gents and HIPH. This partnership will give us a foothold in Asia and allow us to pursue many opportunities across the continent. While I am in China, I will be also having conversations with regional beverage distributors who are interested in our Hydrogen CBD product."

HIPH has previously announced it has a created a hydrogen infused CBD beverage under the LALPINA Hydrogen CBD brand. The Company still anticipates the product will be available for sale by June or earlier. Cannabinoid, a natural phycannbinoid extracted from cannabis is just being introduced in Asian countries, including China, and these markets offer tremendous opportunity to grow by establishing a first to market in these countries.

Establishing a foothold in the continent will give HIPH a potential strategic advantage over other competitors in the CBD space who have focused on domestic markets like PotNetwork Holding Inc (POTN), Rocky Mountain HIgh Brands (RMHB), Isodiol (ISOLF) and Elev8 Brands Inc (VATE)

"Having a foothold in China will allow us to achieve all our strategic growth objectives. I hope our Gents joint venture will be the first of many different partnerships and ventures in China. Now that we are establishing a presence there, I will pursue licensing and JV opportunities with other brands, in line with our growth through acquisition growth initiatives. Also, working with International Monetary, they have a number of relationships in Asia, and I have seen how they were able to leverage them to grow NFusz (FUSZ) which I am confident they can replicate for us"

Please follow us on our social media outlets listed below:

@americanpremium

@lalpinabrands

@GentsCo

#Gentsco

#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s (M), Nordstrom (JWN), and Saks Fifth Avenue (HBC).

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors by Alfred Culbreth, Founder /Director.

Disclaimer Regarding Forward Looking Statements

Certain statements in this press release, on American Premium Water Corporation's ("APWC" website and other oral and written statements made by APWC from time to time are "forward-looking statements", as that term is defined in Section 27A of the United States Securities and Exchange Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, Forward-looking statements include, without limitation, statements regarding beliefs, objectives, intentions, goals, plans, strategies, financial projections, any other statements regarding the future and any statements that are not purely historical. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and APWC expressly disclaims any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date thereof. All forward-looking statements, whether written or oral and whether made by or on behalf of the APWC, are expressly qualified by these cautionary statements. Forward-looking statements involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. APWC’s expectations, beliefs and projections are expressed in good faith and are believed by the APWC to have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. A variety of factors, many of which are beyond APWC's control affect APWC's operations, performance, business strategy and results and could cause the actual results, performance or achievements of APWC to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For APWC, particular uncertainties arise, amongst others but not limited to and not in any order of importance, from (i) focusing on and allocating more resources on certain target markets (ii) the possibility to raise further equity and debt to fund future growth, (iii) changes in demand for APWC's products, (iv) performance issues with key suppliers, affiliates, agents, advisors or subcontractors, (v) changes in government changes in laws or regulations to which APWC or its suppliers are subject, including environmental laws and regulations relating to water or water sources and (vi) the inability to complete announced acquisitions, difficulty or unanticipated expenses in connection with integrating acquired businesses and the risk that anticipated synergies and opportunities as a result of acquisitions will not be realized or the risk that acquisitions do not perform as planned, including, for example, the risk that acquired businesses will not achieve revenue projections.

THIS NEWS RELEASE HAS BEEN PREPARED BY APWC’S MANAGEMENT, WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

Contact Information:

American Premium Water Corporation

12777 Jefferson Blvd.

Suite 300

Playa Vista, CA 90066-7408

(888)-983-0054

Stock Symbol: HIPH

General Inquiries: info@americanpremiumwater.com

Investor Relations: ir@americanpremiumwater.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading